• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial

cafead

Administrator
Staff member
  • cafead   Aug 19, 2022 at 10:42: AM
via CureVac has initiated the Phase I clinical trial of the modified Covid-19 messenger ribonucleic acid (mRNA) vaccine candidate CV0501, to be given as a booster following the initial vaccine series.

article source